ArticleCritical care medicine2010

Risk of death and the efficacy of eritoran tetrasodium (E5564): design considerations for clinical trials of anti-inflammatory agents in sepsis.

Amisha V Barochia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.